How to Check ABH Healthcare IPO Allotment Status

ABH Healthcare Ltd. is a pharmaceutical company engaged in the development, manufacturing and marketing of healthcare products. The company operates in the pharmaceutical sector and serves domestic as well as international markets through its portfolio of healthcare formulations and related products. 

About the ABH Healthcare Ltd. IPO

ABH Healthcare IPO was a book-built public issue that opened for subscription on August 24, 2026 and closed on August 27, 2026. The issue was offered through the book-building route and is proposed to be listed on the NSE SME platform. 

The basis of allotment was scheduled to be finalized following the close of the subscription period. Successful applicants are expected to receive shares in their demat accounts prior to listing, while refunds for unsuccessful applicants would be processed as per the IPO timetable. 

Registrar: Bigshare Services Private Limited 

 NSE: NSE IPO Allotment Status Page 

ABH Healthcare Ltd. IPO Subscription Status

ABH Healthcare IPO attracted investor interest across investor categories during the subscription period. Subscription data released through exchange-based trackers indicated participation from Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs) and Retail Individual Investors (RIIs). 

ABH Healthcare IPO was offered through the book-building route with a prescribed lot size for retail investors. Applicants were required to bid within the specified price band and in the designated lot multiples as outlined in the offer documents. 

The IPO comprised equity shares allocated across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs) and Retail Individual Investors (RIIs) in accordance with SEBI's allocation norms for public issues. 

Based on the final subscription figures, retail investors emerged as the strongest participating category with 1.69 times subscription, while QIB demand remained healthy at 8.37 times subscription. The NII segment, however, remained undersubscribed and closed below the one-time mark. 

With the issue subscribed 1.44 times overall, allotment chances were relatively better than in heavily oversubscribed IPOs. The basis of allotment is expected to be finalized shortly after the issue closure, following which successful applicants will receive shares in their demat accounts and unsuccessful applicants will receive refunds as per the IPO schedule.

ABH Healthcare Ltd. IPO Share Price and Investment Details

ABH Healthcare IPO was offered through the book-building route with a prescribed lot size for retail investors. Applicants were required to bid within the specified price band and in the designated lot multiples as outlined in the offer documents. 

The IPO comprised equity shares allocated across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs) and Retail Individual Investors (RIIs) in accordance with SEBI's allocation norms for public issues. 

Based on the final subscription figures, retail investors emerged as the strongest participating category with 1.69 times subscription, while QIB demand remained healthy at 8.37 times subscription. The NII segment, however, remained undersubscribed and closed below the one-time mark. 

With the issue subscribed 1.44 times overall, allotment chances were relatively better than in heavily oversubscribed IPOs. The basis of allotment is expected to be finalized shortly after the issue closure, following which successful applicants will receive shares in their demat accounts and unsuccessful applicants will receive refunds as per the IPO schedule. 

Utilisation of IPO Proceeds

ABH Healthcare proposes to utilise the proceeds from the fresh issue primarily to support its business expansion plans and strengthen its operational capabilities. The company intends to deploy the capital raised towards enhancing manufacturing capacity, supporting growth initiatives and meeting business requirements as outlined in the offer documents. 

A portion of the proceeds is expected to be utilised towards funding working capital requirements. Additional working capital can help the company support inventory management, expand distribution capabilities and manage day-to-day operational needs more effectively. 

The company may also utilise part of the issue proceeds for general corporate purposes, including strategic initiatives, brand development and strengthening its overall financial position. 

Since the IPO includes an offer-for-sale component, ABH Healthcare will not receive the proceeds attributable to shares sold by the existing shareholders. Those proceeds will be received directly by the selling shareholders. 

The utilisation mix indicates that the fresh capital is aimed at supporting business growth, improving operational efficiency and providing additional financial flexibility for the company's future expansion plans.